Cleared Traditional

K221528 - Fogarty Dilation Atrioseptostomy Catheter

K221528 is the FDA 510(k) clearance for Fogarty Dilation Atrioseptostomy Catheter by Edwards Lifesciences, LLC. It is a Class 2 Cardiovascular device (product code DXF) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K221528 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
88d
Days
Class 2
Risk

K221528 is an FDA 510(k) clearance for the Fogarty Dilation Atrioseptostomy Catheter, Miller Balloon Atrioseptostomy Cat.... Classified as Catheter, Septostomy (product code DXF), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on August 22, 2022 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5175 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Edwards Lifesciences, LLC devices

Submission Details

510(k) Number K221528 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 2022
Decision Date August 22, 2022
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 125d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXF Catheter, Septostomy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5175
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXF Catheter, Septostomy

All 15
Devices cleared under the same product code (DXF) and FDA review panel - the closest regulatory comparables to K221528.
CrossWise RF Transseptal Access System (Models: CW-1085S, CW-1085A, CW-1012W, CW-1012C)
K241414 · Circa Scientific, Inc. · Sep 2024
HOTWIRE™ RF Guidewire
K240900 · Atraverse Medical · May 2024
Cross Vascular RF Transseptal Needle, Cross Vascular Connection Cable
K232852 · Cross Vascular, Inc. · Oct 2023
Z-6 Atrioseptostomy Catheter
K211910 · NuMED, Inc. · Jul 2021
Park Blade Septostomy Catheter
K182399 · Cook Incorporated · Apr 2019
PTA, PTV, ATRIOSEPTOSTOMY, ANGIOGRAPHIC, SIZING CATHETERS
K011557 · NuMED, Inc. · Jul 2001